Roche announced last month (October 2011) that the Phase III HannaH study demonstrated that a new, subcutaneous (SC) formulation of Herceptin (trastuzumab) performed similarly to the standard intra
Patients with life-threatening Pompe disease will march on Parliament this week (Nov 16, 2011) to call for a commitment from all political parties for treatment of their disease, and to put in plac
BCAC was formed in November 2004 with twelve member groups and now, in 2011, we have 32 breast cancer-related member groups and around 50 individual members.
The Breast Cancer Aotearoa Coalition (BCAC) will hold its annual general meeting on the evening of Friday, 4th November 2011 at 7 pm in the New Zealand Cancer Society Offices, Domain Lodge at 1 Boy